Gerrit Dispersyn
2021
In 2021, Gerrit Dispersyn earned a total compensation of $751.5K as Former President and Chief Executive Officer at RXi Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $136,688 |
|---|---|
| Salary | $403,390 |
| Stock Awards | $210,826 |
| Other | $575 |
| Total | $751,479 |
Dispersyn received $403.4K in salary, accounting for 54% of the total pay in 2021.
Dispersyn also received $136.7K in non-equity incentive plan, $210.8K in stock awards and $575 in other compensation.
Rankings
In 2021, Gerrit Dispersyn's compensation ranked 9,678th out of 12,415 executives tracked by ExecPay. In other words, Dispersyn earned more than 22.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,678 out of 12,415 | 22nd |
Division Manufacturing | 4,285 out of 5,508 | 22nd |
Major group Chemicals And Allied Products | 1,897 out of 2,378 | 20th |
Industry group Drugs | 1,683 out of 2,099 | 20th |
Industry Pharmaceutical Preparations | 1,252 out of 1,549 | 19th |
Source: SEC filing on June 9, 2023.
Dispersyn's colleagues
We found two more compensation records of executives who worked with Gerrit Dispersyn at RXi Pharmaceuticals in 2021.